3KDOQI,National Kidney Foundation.KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease[J].Am J Kidney Dis,2006,47(5 Suppl 3):S11-145.
4Tsai IJ,Berlin W,Puddey IB,et al.Impaire ex vivo leukotriene B4 production characterizes the metabolic syndrome and is improved after weight reduction[J].J Clin Endocrinol Metab,2007,92(12):4747-4752.
5Parfrey PS,Lauve M,Latremouille-Viau D,et al.Erythropoietin therapy and left ventricular mass index in CKD and ESRD patients:a meta-analysis[J].Clin J Am Soc Nephrol,2009,4(4):755-762.
6Rozen-Zvi B,Gafter-Gvili A,Paul M,et al.Intravenous versus oral iron supplementation for the treatment of anemia in CKD:systematic review and meta-analysis[J].Am J Kidney Dis,2008,52(5):897-906.
